11 – 20 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
- Contribution to journal › Article
-
Mark
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
- Contribution to journal › Article
-
Mark
Ciclopirox Ethanolamine Preserves the Immature State of Human HSCs by Mediating Intracellular Iron Content
- Contribution to journal › Article
-
Mark
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
- Contribution to journal › Article
-
Mark
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B
- Contribution to journal › Article
-
Mark
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
- Contribution to journal › Article
-
Mark
Single-cell multiomics of human fetal hematopoiesis define a developmental-specific population and a fetal signature
- Contribution to journal › Article
-
Mark
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
- Contribution to journal › Article
- 2022
-
Mark
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
- Contribution to journal › Article
-
Mark
Dissecting platelet proteomics to understand the pathophysiology of immune thrombocytopenia : studies in mouse models
- Contribution to journal › Article
